데이터셋 상세
미국
Approved Risk Evaluation and Mitigation Strategies
The Food and Drug Administration Amendments Act of 2007 gave FDA the authority to require a Risk Evaluation and Mitigation Strategy (REMS) from manufacturers to ensure that the benefits of a drug or biological product outweigh its risks.
데이터 정보